NLRP3 and cerebral infarction: MCC950, an NLRP3 inhibitor, can reduce the expression of NLRP3 in ischemic brain tissue, and we have discovered that an NLRP3 inhibitor can reduce neuronal apoptosis, cerebral infarct size, and neurological dysfunction [37].